FORMULATIONS TRANSDERMIQUES POUR L'ADMINISTRATION DE DOXYCYCLINE ET LEUR UTILISATION DANS LE TRAITEMENT DE MALADIES ET DE PATHOLOGIES SENSIBLES À LA DOXYCYCLINE
The present application is directed to transdermal formulations for the delivery of doxycycline compounds to a subject for the treatment of doxycycline-responsive diseases. In particular, the transdermal formulation is an emulsion comprising an oil phase, an aqueous phase and an external phase.